72. Unlocking biologic drug production, Brian Finrow, Co-Founder and CEO, Lumen Bioscience
Brian Finrow brings the skills and experience of a lawyer to a position that, in the biotech world, is more typically occupied by a scientist. This is essential to an enterprise like Lumen, which is r...
22 Syys 202120min
71. Leadership in immuno-oncology, Jeffrey Goldberg, President and CEO, Immunitas Therapeutics
Jeffrey Goldberg is the president and CEO of Immunitas. Jeff is an experienced biotech program and brand leader with over 20 years of industry experience. He has driven programs from discovery and pre...
15 Syys 202121min
70. Modern treatments for psoriasis and atopic dermatitis, Todd Zavodnick, CEO, Dermavant Sciences
Todd Zavodnick has over 20 years of leadership experience in the biopharmaceutical industry. Prior to joining Dermavant in November 2018, Mr. Zavodnick served as Chief Commercial Officer and President...
25 Elo 202128min
69. Antibodies in immuno-oncology, Alison O'Neill, Chief Medical Officer, Surface Oncology
Alison serves as the chief medical officer at Surface Oncology. She has over 20 years of experience in clinical research, oncology drug development and clinical neuro-oncology. Prior to joining Surfac...
18 Elo 202119min
68. Patient-focused Wet AMD, Nancy Lurker, President & CEO, Said Saim, CTO, EyePoint Pharmaceuticals
Nancy Lurker: President & Chief Executive Officer Our President, CEO, and a director since September 2016, Ms Lurker has broad-ranging experience in the pharmaceutical industry and a track record of m...
11 Elo 202128min
67. ML protein therapy, Mike Nally, CEO, and Geoff von Maltzahn, Co-Founder, Generate Biomedicines
Mike Nally is the Chief Executive Officer of Generate Biomedicines and a CEO-Partner at Flagship Pioneering. Mike brings significant experience leading global organizations and is passionate about wor...
4 Elo 202136min
66. I’ll take “Wild Rides” for 500, Alex: Biotech Entrepreneur’s Story, Ron Cohen, CEO, Acorda
Ron Cohen, M.D. is President, CEO and founder of Acorda Therapeutics, Inc., a public biotechnology company developing therapies for disorders of the nervous system, including multiple sclerosis, Parki...
28 Heinä 202140min
65. Patient focused precision oncology, Avanish Vellanki, Cofounder and CEO, Rain Therapeutics
Avanish Vellanki is passionate about offering cancer patients better treatment options, and he firmly believes that precision oncology strategies are the best manner in which to achieve that goal. He ...
21 Heinä 202129min
